# Use Dexmedetomidine To Protect Myocardial Injury Evaluation

> **NCT07549282** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 1800 (estimated)

## Conditions studied

- Coronary Heart Disease
- Myocardial Injury
- Myocardial Infarction
- Dexmedetomidine

## Interventions

- **DRUG:** Intranasal Dexmedetomidine
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT07549282
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2028-01
- **Final completion:** 2028-04
- **Target enrollment:** 1800 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07549282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07549282, "Use Dexmedetomidine To Protect Myocardial Injury Evaluation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07549282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*